探索由蛋白质分解诱导的内在无序蛋白质的降解 是-关联蛋白质 准金马
Chen Zhou1, Chunbao Sun2, Miao Huang3,4
1Department of Medicinal Chemistry, College of Pharmacy, University of Florida, Gainesville, Florida 32610, United States.
Journal of medicinal chemistry
|August 27, 2024
概括
科学家们开发了针对YAP的新型降解剂,使用向蛋白质溶解的嵌合体技术. 这些降解剂有效地降低了YAP的致癌活性,显示了治疗YAP驱动癌症的前景.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 是的相关蛋白 (YAP) 是Hippo通路中的一个关键瘤基因.
- 对于传统的药物向来说,YAP本质上的混乱性质带来了挑战.
- 最近的进展确定了YAP结合剂,使新的治疗策略成为可能.
研究的目的:
- 为YAP开发向蛋白质分解的嵌合体 (PROTAC) 降解剂.
- 评估这些降解剂在抑制YAP活性和扩散方面的有效性.
主要方法:
- 采用了向蛋白质溶解的嵌合体 (PROTAC) 技术.
- 通过将 YAP 结合剂 (例如,NSC682769) 与 E3 酶配体 (VHL 配体 2,波马利多米德) 结合,合成了 YAP 降解剂.
- 在癌症细胞系 (NCI-H226,Huh7) 和异种移植小鼠模型中评估了降解效果.
主要成果:
- 开发了包括YZ-6在内的新型YAP降解剂,可以诱导快速和持续的YAP降解.
- 降解剂抑制了YAP核定位和YAP/TEAD介导的转录.
- 在实验室和体内证明有强大的抗增殖作用,在Huh7异种移植模型中减少瘤生长.
结论:
- 通过PROTAC介导的YAP降解是针对YAP驱动癌症的可行策略.
- 开发的降解剂显示出癌症治疗的巨大潜力.
- 这种方法克服了与针对YAP等内在无序蛋白质相关的挑战.
相关概念视频
Export of Misfolded Proteins out of the ER
3.5K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.5K
The Unfolded Protein Response
4.5K
The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
4.5K
The Proteasome
818
Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
818
Regulated Protein Degradation
7.2K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
7.2K
Molecular Chaperones and Protein Folding
17.8K
The native conformation of a protein is formed by interactions between the side chains of its constituent amino acids. When the amino acids cannot form these interactions, the protein cannot fold by itself and needs chaperones. Notably, chaperones do not relay any additional information required for the folding of polypeptides; the native conformation of a protein is determined solely by its amino acid sequence. Chaperones catalyze protein folding without being a part of the folded protein.
The...
The...
17.8K
Regulation of the Unfolded Protein Response
2.4K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.4K


